ASMER2: A Potential Drug Target and Biomarker (G105373202)

Target Name: ASMER2

NCBI ID: G105373202

ASMER2

Other Name(s): ASMER-2 | LOC105373202 | adipocyte associated metabolic related lncRNA 2 | Uncharacterized LOC105373202

ASMER2: A Potential Drug Target and Biomarker

ASMER2 (ASMER-2) is a protein that is expressed in various tissues of the body, including the brain, heart, lungs, and gastrointestinal tract. It is a member of the ASMER family of proteins, which are known for their role in the regulation of cell signaling pathways. Recent studies have identified ASMER2 as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

The ASMER2 protein is known for its ability to interact with multiple signaling pathways, including the NF-kappa pathway, the Wnt pathway, and theNotch pathway. NF-kappa is a well-known signaling pathway that plays a crucial role in the development and maintenance of tissues, including the brain. The NF-kappa pathway is involved in the regulation of cell proliferation, differentiation, and survival, and is often disrupted in various diseases, including cancer.

ASMER2 has been shown to play a role in the regulation of NF-kappa signaling in various tissues. For example, studies have shown that ASMER2 can inhibit the activity of the NF-kappa receptor, leading to reduced signaling through the pathway. This has led to the speculation that ASMER2 may be a potential drug target for NF-kappa-related diseases.

In addition to its role in NF-kappa signaling, ASMER2 has also been shown to be involved in the regulation of other signaling pathways, including the Wnt pathway and theNotch pathway. The Wnt pathway is involved in the regulation of cell growth and differentiation, and is often disrupted in neurodegenerative diseases. TheNotch pathway is involved in the regulation of cell survival and proliferation, and is also disrupted in various diseases, including neurodegenerative diseases.

ASMER2 has been shown to play a role in the regulation of Wnt signaling in various tissues. For example, studies have shown that ASMER2 can inhibit the activity of the Wnt receptor, leading to reduced signaling through the pathway. This has led to the suggestion that ASMER2 may be a potential drug target for Wnt-related diseases.

In addition to its role in Wnt signaling, ASMER2 has also been shown to be involved in the regulation of cell survival and proliferation. This has led to the assumption that ASMER2 may be a potential biomarker for diseases that are characterized by uncontrolled cell growth and proliferation. , such as cancer.

ASMER2 has also been shown to play a role in the regulation of the Notch pathway in various tissues. For example, studies have shown that ASMER2 can inhibit the activity of the Notch receptor, leading to reduced signaling through the pathway. This has led to the suggestion that ASMER2 may be a potential drug target for Notch-related diseases.

In conclusion, ASMER2 is a protein that is involved in the regulation of multiple signaling pathways, including NF-kappa, Wnt, and Notch. Its potential as a drug target and biomarker for various diseases makes ASMER2 a promising target for future research. Further studies are needed to fully understand the role of ASMER2 in the regulation of cell signaling pathways and its potential as a drug target and biomarker for various diseases.

Protein Name: Adipocyte Associated Metabolic Related LncRNA 2

The "ASMER2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ASMER2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets